← Back to Search

Home-Based Palliative Care for Kidney Failure (SHEPHERD 2 Trial)

N/A

Waitlist Available

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be an adult (18 years of age or older) hospitalized at a Penn study hospital

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1- and 3-months

Awards & highlights

No Placebo-Only Group

Summary

This trial will evaluate if referrals to home palliative care services improve outcomes for patients with ESRD. Increasing access to these services could improve patient care.

Who is the study for?

This trial is for adults over 18 with End-Stage Renal Disease (ESRD) who've been hospitalized at a Penn hospital, live in the surrounding Philadelphia area, and show signs of needing more care at home. They shouldn't already be receiving palliative care but may have had multiple hospitalizations or other health issues like severe malnutrition.

What is being tested?

The study tests if 'nudging' ESRD patients towards home palliative care services after they leave the hospital helps improve their quality of life compared to usual care without these extra services. It's about seeing if more support at home makes a difference.

What are the potential side effects?

Since this trial involves referrals to supportive care rather than medication, there are no direct side effects from drugs. However, changes in healthcare management could affect patient comfort and well-being.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older and hospitalized at a Penn study hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1- and 3-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1- and 3-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1- and 3-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acute Encounters

Secondary study objectives

Health-Related Quality of Life

Home Palliative Care Visits

Hospice Enrollment

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

The inpatient care team, including the attending/ordering and covering providers, for participants in this group will receive a message from the research team identifying their patient as appropriate for home palliative care and will be asked to refer their patient for these services.

Group II: Usual CareActive Control1 Intervention

Participants in this group will receive usual care upon discharge from the hospital. Their clinical team will not be notified that they are appropriate for home palliative care services, but they may still be referred for those services if their clinicians feel their patient will benefit.

0 / 1Eligibility criteria met